CD44 and cancer: The transmembrane glycoprotein CD44 is one of the adhesion molecules present on hematological cancer cells and also identified as one of the cell surface antigens preferentially expressed on cancer stem cells in human hematological carcinomas (Misaghian et al., 2009; Zöller, 2011).